Cresco Labs (CRLBF) Intangibles (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Intangibles came in at $288.4 million in Q1 2026, down 1.66% YoY from $293.3 million in Q1 2025, and up 4.76% on a QoQ basis from $275.3 million in Q4 2025.
Cresco Labs (CRLBF) Intangibles (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Intangibles data on file, last reported at $288.4 million in Q1 2026.
- Quarterly Intangibles fell 1.66% year-over-year to $288.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.4 million (down 1.66% YoY) and the FY2025 annual result came in at $275.3 million, down 6.34% from the prior year.
- Intangibles rose to $288.4 million in Q1 2026, from $275.3 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $435.9 million in Q1 2022 to a low of $275.3 million in Q4 2025.
- A 5-year average of $337.5 million and a median of $298.0 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles jumped 655.6% — and 2023, when it slumped 30.93%.
- Tracing CRLBF's Intangibles over 5 years: stood at $407.6 million in 2022, then declined by 27.14% to $297.0 million in 2023, then declined by 1.0% to $294.0 million in 2024, then dropped by 6.34% to $275.3 million in 2025, then climbed by 4.76% to $288.4 million in 2026.
- The last three Intangibles figures came in at $288.4 million (Q1 2026), $275.3 million (Q4 2025), and $292.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 321.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.45 Mn |
| Dec 31, 2025 | 275.34 Mn |
| Sep 30, 2025 | 292.00 Mn |
| Jun 30, 2025 | 289.27 Mn |
| Mar 31, 2025 | 293.32 Mn |
| Dec 31, 2024 | 293.99 Mn |
| Sep 30, 2024 | 295.65 Mn |
| Jun 30, 2024 | 299.99 Mn |
| Mar 31, 2024 | 298.07 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 298.01 Mn |
| Jun 30, 2023 | 402.80 Mn |
| Mar 31, 2023 | 406.10 Mn |
| Dec 31, 2022 | 407.59 Mn |
| Sep 30, 2022 | 431.45 Mn |
| Jun 30, 2022 | 433.35 Mn |
| Mar 31, 2022 | 435.93 Mn |
| Dec 31, 2021 | 437.64 Mn |
| Sep 30, 2021 | 57.10 Mn |
| Mar 31, 2021 | 215.25 Mn |